Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 1866612)

Published in Am J Pathol on June 01, 1999

Authors

E Rodríguez-Iñigo1, J Bartolomé, S de Lucas, F Manzarbeitia, M Pardo, C Arocena, J Gosálvez, H Oliva, V Carreño

Author Affiliations

1: Department of Hepatology, Fundación Jiménez Díaz and Fundación Estudio Hepatitis Virales, Madrid, Spain.

Articles cited by this

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24

Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet (1993) 4.51

Hepatitis C: the clinical spectrum of disease. Hepatology (1997) 3.94

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis (1994) 1.71

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology (1993) 1.46

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology (1993) 1.31

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut (1998) 1.20

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19

Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci (1994) 1.15

Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol (1996) 1.13

Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology (1994) 1.11

Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology (1998) 1.08

Hepatitis C virus: quantitation and distribution in liver. J Med Virol (1997) 1.03

Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood (1994) 1.01

Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis (1992) 0.96

Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology (1993) 0.92

HCV viraemia and liver injury in symptom-free blood donors. Lancet (1993) 0.87

Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay. J Clin Microbiol (1997) 0.87

Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C. J Hepatol (1995) 0.83

Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region. J Clin Invest (1992) 0.83

Articles by these authors

Specific detection of Brucella DNA by PCR. J Clin Microbiol (1995) 2.03

Idiopathic biliary ductopenia in adults without symptoms of liver disease. N Engl J Med (1997) 1.65

Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain) Eur Respir J (1996) 1.63

Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut (2005) 1.49

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A (2005) 1.45

The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry (1999) 1.43

Ribozymes: structure, characteristics and use as potential antiviral agents. J Hepatol (1995) 1.42

[Macrocytic anemia and dysphagia]. Rev Clin Esp (1994) 1.40

Magnetic relaxation of interacting co clusters: crossover from two- to three-dimensional lattices. Phys Rev Lett (2002) 1.40

Retreatment of chronic hepatitis C virus infection. Lancet (1994) 1.39

[Septic pulmonary embolism secondary to a focus of peridental osteitis]. Arch Bronconeumol (1994) 1.39

[Relation between prostate gland volume and some histological markers of malignancy]. Actas Urol Esp (2011) 1.39

[Hepatitis C virus and cryoglobulinemia]. Rev Clin Esp (1992) 1.39

[Expert opinion on the basic surgical technique for laparoscopic ventral hernia repair]. Cir Esp (2005) 1.39

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology (2000) 1.38

Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science (1968) 1.35

Vascular leiomyosarcoma: the malignant counterpart of vascular leiomyoma. Cancer (1979) 1.32

Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31

Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol (1994) 1.31

Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology (2001) 1.26

The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo. Am J Pathol (1971) 1.25

Subduction and collision processes in the Central Andes constrained by converted seismic phases. Nature (2001) 1.22

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1999) 1.21

Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis (1997) 1.18

Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathology (1994) 1.16

Bronchobiliary fistula secondary to biliary lithiasis. Treatment by endoscopic sphincterotomy. Dig Dis Sci (1994) 1.16

Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther (2006) 1.16

The function of permanent vascular access. Nephrol Dial Transplant (2000) 1.16

Evaluation of PCR and indirect enzyme-linked immunosorbent assay on milk samples for diagnosis of brucellosis in dairy cattle. J Clin Microbiol (1995) 1.13

In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol (2001) 1.12

Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat (2007) 1.11

In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol (1999) 1.09

Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology (1998) 1.08

Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07

Immunohistochemical localization of a choriogonadotropin-like protein in bacteria isolated from cancer patients. Cancer (1978) 1.07

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus. J Infect Dis (1999) 1.04

Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol (1997) 1.04

In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients. Antiviral Res (1999) 1.02

Sebaceous carcinoma of the vulva. Am J Dermatopathol (1999) 1.01

Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology (2000) 0.99

Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. AIDS (2000) 0.99

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine (1998) 0.99

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol (2000) 0.97

Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension (2001) 0.97

High-resolution imaging of remanent state and magnetization reversal of superdomain structures in high-density cobalt antidot arrays. Nanotechnology (2014) 0.97

Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology (1993) 0.97

[Cystic diseases of the lung: high-resolution computed tomography findings]. Arch Bronconeumol (2005) 0.96

Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach. Am J Physiol Endocrinol Metab (2010) 0.96

Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics (2001) 0.95

A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules. Antiviral Res (1987) 0.95

Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology (1991) 0.95

Semiquantification by Amplicor assay of hepatitis C virus genome during therapy. J Hepatol (1995) 0.95

Electron microscope study on the replication of AAV-1 in herpes-infected cells. Virology (1972) 0.95

Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay. J Med Virol (1996) 0.94

BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol (2003) 0.94

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. Gastroenterology (1997) 0.94

IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology (1991) 0.93

Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion. J Hepatol (1994) 0.93

Ultrastructure of a fibroxanthosarcoma (malignant fibroxanthoma). Cancer (1971) 0.93

[Guidelines on hemodialysis-associated viral infections]. Nefrologia (2004) 0.93

Irisin: 'fat' or artefact. Clin Endocrinol (Oxf) (2014) 0.93

Pneumothorax in AIDS patients: operative management. Am Surg (1993) 0.92

Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood (1997) 0.92

Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon. Liver (1987) 0.92

Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology (1999) 0.92

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol (1992) 0.91

Dynamics of sperm DNA fragmentation in patients carrying structurally rearranged chromosomes. Int J Androl (2011) 0.91

A cellular and malignant blue nevus: a light and electron microscopic study. Cancer (1969) 0.91

Immuno-electron microscopic localization of a choriogonadotropin-like antigen in cancer-associated bacteria. Oncology (1979) 0.91

Fluorescent "in situ" hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Med Virol (2000) 0.91

Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int (1998) 0.91

Concentrated ascitic fluid reinfusion in cirrhotic patients: a simplified method. Am J Kidney Dis (1997) 0.91

DBD-fish on neutral comets: simultaneous analysis of DNA single- and double-strand breaks in individual cells. Exp Cell Res (2001) 0.91

Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. J Pharmacol Exp Ther (1977) 0.90

Membranous glomerulonephritis as a complication of oral gold therapy. Ann Intern Med (1982) 0.90